NeoNeuro Awarded a New BPI France Grant NeoNeuro recently received a new grant from BPI France to advance research on developing aptamers as diagnostic and therapeutic tools for Alzheimer’s disease. This funding enables our team… 

NeoNeuro Receives BPI France Grant NeoNeuro has received support from BPI France under the PIA-1 program to advance the use of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease. This funding allows our team…